2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-10-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11555613 2023-10-01 2024-09-30 11555613 2024-09-30 11555613 2023-09-30 11555613 2022-10-01 2023-09-30 11555613 2023-09-30 11555613 2022-09-30 11555613 bus:Director1 2023-10-01 2024-09-30 11555613 core:WithinOneYear 2024-09-30 11555613 core:WithinOneYear 2023-09-30 11555613 bus:Micro-entities 2023-10-01 2024-09-30 11555613 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 11555613 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 11555613 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 11555613 bus:FullAccounts 2023-10-01 2024-09-30
COMPANY REGISTRATION NUMBER: 11555613
BNL Pharma Solutions Ltd
Filleted Unaudited Financial Statements
For the period ended
30 September 2024
BNL Pharma Solutions Ltd
Statement of Financial Position
30 September 2024
2024
2023
£
£
Fixed assets
4,263
2,837
-------
-------
Current assets
35,797
37,541
Creditors: amounts falling due within one year
39,116
28,012
--------
--------
Net current (liabilities)/assets
( 3,319)
9,529
-------
--------
Total assets less current liabilities
944
12,366
Accruals and deferred income
17,034
----
--------
944
(4,668)
----
--------
Capital and reserves
944
( 4,668)
----
-------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
2. Directors' advances, credits and guarantees
During the year the directors received net advances totalling £9,725 which was still outstanding at the period end. The maximum outstanding at any time during the period was £10,000. The loan is repayable on demand. Interest was charged at 2.25% on the average balance outstanding.
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 27 November 2024 , and are signed on behalf of the board by:
Mr J Harker
Director
Company registration number: 11555613
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is The Whitehouse, Denchworth Road, Grove, Wantage, Oxfordshire, OX12 0AR.